Concepts (280)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proton Pump Inhibitors | 6 | 2024 | 529 | 0.990 |
Why?
|
| Organic Anion Transporters, Sodium-Independent | 4 | 2024 | 28 | 0.870 |
Why?
|
| Reperfusion Injury | 5 | 2015 | 1022 | 0.860 |
Why?
|
| Cytochrome P-450 CYP3A | 4 | 2022 | 114 | 0.790 |
Why?
|
| Intestinal Absorption | 3 | 2014 | 400 | 0.770 |
Why?
|
| Cyclosporine | 3 | 2015 | 777 | 0.690 |
Why?
|
| Antimetabolites, Antineoplastic | 2 | 2019 | 638 | 0.630 |
Why?
|
| Gout Suppressants | 1 | 2019 | 177 | 0.600 |
Why?
|
| Liver | 6 | 2019 | 7502 | 0.590 |
Why?
|
| Cimetidine | 2 | 2015 | 76 | 0.570 |
Why?
|
| Bronchial Neoplasms | 1 | 2017 | 110 | 0.550 |
Why?
|
| Folic Acid Antagonists | 1 | 2016 | 75 | 0.540 |
Why?
|
| Chromans | 2 | 2013 | 117 | 0.510 |
Why?
|
| Kidney Diseases | 3 | 2020 | 2083 | 0.500 |
Why?
|
| Hematologic Tests | 1 | 2016 | 238 | 0.500 |
Why?
|
| Pharmacokinetics | 1 | 2014 | 86 | 0.450 |
Why?
|
| Methotrexate | 2 | 2019 | 1719 | 0.450 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2015 | 414 | 0.440 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2013 | 58 | 0.440 |
Why?
|
| Tight Junctions | 2 | 2022 | 316 | 0.430 |
Why?
|
| MicroRNAs | 4 | 2024 | 3783 | 0.400 |
Why?
|
| Antiporters | 1 | 2013 | 278 | 0.400 |
Why?
|
| Kidney | 6 | 2020 | 7016 | 0.390 |
Why?
|
| Rats, Wistar | 6 | 2020 | 1844 | 0.360 |
Why?
|
| Fetal Growth Retardation | 3 | 2019 | 579 | 0.360 |
Why?
|
| Intestinal Mucosa | 3 | 2012 | 3020 | 0.350 |
Why?
|
| Intestine, Small | 2 | 2012 | 1207 | 0.310 |
Why?
|
| Carrier Proteins | 2 | 2014 | 4938 | 0.310 |
Why?
|
| Hydrogen Peroxide | 3 | 2019 | 728 | 0.310 |
Why?
|
| Liver Circulation | 1 | 2008 | 159 | 0.310 |
Why?
|
| Copper | 3 | 2020 | 366 | 0.300 |
Why?
|
| Lymphoma | 1 | 2017 | 1896 | 0.300 |
Why?
|
| Neoplasm Proteins | 1 | 2019 | 3609 | 0.290 |
Why?
|
| Kidney Function Tests | 2 | 2019 | 677 | 0.270 |
Why?
|
| Sarcoma | 1 | 2017 | 1785 | 0.260 |
Why?
|
| Carcinoma | 1 | 2017 | 2330 | 0.260 |
Why?
|
| Oxidative Stress | 3 | 2020 | 3099 | 0.250 |
Why?
|
| Biopsy | 1 | 2017 | 6768 | 0.250 |
Why?
|
| Intestines | 2 | 2022 | 1906 | 0.250 |
Why?
|
| Pre-Eclampsia | 3 | 2019 | 1227 | 0.240 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2019 | 675 | 0.240 |
Why?
|
| Vasodilator Agents | 2 | 2019 | 973 | 0.240 |
Why?
|
| Intestinal Diseases | 1 | 2009 | 505 | 0.240 |
Why?
|
| Thymine | 1 | 2024 | 68 | 0.230 |
Why?
|
| Aflatoxin B1 | 1 | 2022 | 17 | 0.210 |
Why?
|
| Acrylamides | 1 | 2024 | 259 | 0.210 |
Why?
|
| Cisplatin | 2 | 2020 | 1645 | 0.210 |
Why?
|
| Rats | 9 | 2024 | 23679 | 0.200 |
Why?
|
| Pyrrolidines | 1 | 2024 | 337 | 0.200 |
Why?
|
| HEK293 Cells | 5 | 2024 | 4257 | 0.200 |
Why?
|
| Caco-2 Cells | 3 | 2022 | 364 | 0.190 |
Why?
|
| Doxorubicin | 2 | 2018 | 2209 | 0.190 |
Why?
|
| Pathology | 1 | 2024 | 270 | 0.190 |
Why?
|
| Idarubicin | 1 | 2020 | 59 | 0.180 |
Why?
|
| Frontotemporal Dementia | 1 | 2024 | 246 | 0.180 |
Why?
|
| Liver Diseases | 1 | 2009 | 1296 | 0.180 |
Why?
|
| DNA Damage | 3 | 2020 | 2439 | 0.180 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 2 | 2019 | 101 | 0.180 |
Why?
|
| Epithelial Cells | 1 | 2012 | 3664 | 0.180 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2024 | 11709 | 0.180 |
Why?
|
| Aclarubicin | 1 | 2019 | 12 | 0.170 |
Why?
|
| Pregnancy, Animal | 1 | 2019 | 124 | 0.170 |
Why?
|
| Protective Agents | 1 | 2020 | 150 | 0.160 |
Why?
|
| Aniline Compounds | 1 | 2024 | 1068 | 0.160 |
Why?
|
| Antihypertensive Agents | 3 | 2021 | 2016 | 0.160 |
Why?
|
| Colonic Neoplasms | 2 | 2024 | 2523 | 0.160 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2018 | 69 | 0.160 |
Why?
|
| Drug Synergism | 2 | 2019 | 1745 | 0.160 |
Why?
|
| Melanoma | 1 | 2017 | 5691 | 0.160 |
Why?
|
| Anthracyclines | 1 | 2020 | 282 | 0.160 |
Why?
|
| Liver Function Tests | 1 | 2019 | 523 | 0.150 |
Why?
|
| Enoxaparin | 1 | 2020 | 392 | 0.150 |
Why?
|
| Fetal Heart | 1 | 2019 | 281 | 0.150 |
Why?
|
| Antineoplastic Agents | 5 | 2024 | 13591 | 0.150 |
Why?
|
| Apoptosis | 4 | 2024 | 9468 | 0.150 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2023 | 708 | 0.150 |
Why?
|
| Carcinoma, Embryonal | 1 | 2017 | 37 | 0.150 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2017 | 260 | 0.140 |
Why?
|
| Tonsillar Neoplasms | 1 | 2017 | 50 | 0.140 |
Why?
|
| Tacrolimus | 1 | 2020 | 733 | 0.140 |
Why?
|
| Tomography | 1 | 2019 | 411 | 0.140 |
Why?
|
| Thrombocytopenia | 1 | 2024 | 1171 | 0.130 |
Why?
|
| Living Donors | 1 | 2020 | 638 | 0.130 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2017 | 251 | 0.130 |
Why?
|
| Kidney Transplantation | 2 | 2021 | 4217 | 0.130 |
Why?
|
| Uterus | 1 | 2019 | 651 | 0.130 |
Why?
|
| Down-Regulation | 2 | 2013 | 2904 | 0.130 |
Why?
|
| Thymoma | 1 | 2017 | 187 | 0.130 |
Why?
|
| Biological Transport | 2 | 2024 | 2084 | 0.120 |
Why?
|
| Pyridones | 1 | 2020 | 784 | 0.120 |
Why?
|
| Drug Interactions | 2 | 2018 | 1414 | 0.120 |
Why?
|
| Rectal Neoplasms | 1 | 2024 | 1152 | 0.120 |
Why?
|
| Male | 22 | 2024 | 358747 | 0.120 |
Why?
|
| Cytomegalovirus Infections | 1 | 2021 | 831 | 0.120 |
Why?
|
| Blood Coagulation | 1 | 2020 | 1149 | 0.120 |
Why?
|
| Thymus Neoplasms | 1 | 2017 | 274 | 0.120 |
Why?
|
| Retrospective Studies | 9 | 2024 | 80168 | 0.120 |
Why?
|
| Colorectal Neoplasms | 2 | 2024 | 6852 | 0.110 |
Why?
|
| Cell Line | 3 | 2019 | 15591 | 0.110 |
Why?
|
| Carboplatin | 1 | 2016 | 788 | 0.110 |
Why?
|
| Heparin | 1 | 2020 | 1632 | 0.110 |
Why?
|
| Cytoskeleton | 1 | 2018 | 1167 | 0.110 |
Why?
|
| Leiomyosarcoma | 1 | 2017 | 424 | 0.110 |
Why?
|
| Light | 1 | 2019 | 1345 | 0.100 |
Why?
|
| Glutathione | 2 | 2012 | 579 | 0.100 |
Why?
|
| Skin Diseases | 1 | 2021 | 1088 | 0.100 |
Why?
|
| Malondialdehyde | 1 | 2012 | 111 | 0.100 |
Why?
|
| Animals | 16 | 2024 | 167768 | 0.100 |
Why?
|
| Middle Aged | 12 | 2024 | 219568 | 0.100 |
Why?
|
| Temperature | 1 | 2019 | 2219 | 0.100 |
Why?
|
| Fluorouracil | 1 | 2017 | 1631 | 0.100 |
Why?
|
| Synaptic Transmission | 1 | 2018 | 1169 | 0.100 |
Why?
|
| Humans | 31 | 2024 | 758406 | 0.100 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2014 | 411 | 0.100 |
Why?
|
| Drug Therapy | 1 | 2015 | 503 | 0.100 |
Why?
|
| Antioxidants | 2 | 2012 | 1662 | 0.100 |
Why?
|
| Pyrrolidinones | 1 | 2011 | 116 | 0.090 |
Why?
|
| Survival Analysis | 2 | 2021 | 10112 | 0.090 |
Why?
|
| Glucuronosyltransferase | 1 | 2011 | 130 | 0.090 |
Why?
|
| Aged | 11 | 2024 | 168218 | 0.090 |
Why?
|
| Fluorescent Dyes | 1 | 2019 | 1897 | 0.090 |
Why?
|
| Female | 18 | 2024 | 390323 | 0.090 |
Why?
|
| Interleukin-6 | 1 | 2020 | 3208 | 0.090 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2014 | 563 | 0.090 |
Why?
|
| 3' Untranslated Regions | 1 | 2012 | 514 | 0.090 |
Why?
|
| Hematopoiesis | 1 | 2019 | 2047 | 0.090 |
Why?
|
| Pyrazoles | 1 | 2020 | 1988 | 0.090 |
Why?
|
| Liver Transplantation | 2 | 2015 | 2325 | 0.090 |
Why?
|
| Bile Acids and Salts | 1 | 2012 | 383 | 0.090 |
Why?
|
| Diagnostic Imaging | 1 | 2024 | 3526 | 0.090 |
Why?
|
| Depsipeptides | 1 | 2010 | 95 | 0.090 |
Why?
|
| Adult | 12 | 2024 | 219935 | 0.090 |
Why?
|
| Cell Survival | 1 | 2019 | 5781 | 0.080 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 2551 | 0.080 |
Why?
|
| Triglycerides | 1 | 2017 | 2451 | 0.080 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2024 | 5249 | 0.080 |
Why?
|
| Medication Adherence | 1 | 2021 | 2155 | 0.080 |
Why?
|
| Blood Pressure | 3 | 2021 | 8451 | 0.080 |
Why?
|
| Hydroxylation | 1 | 2008 | 137 | 0.080 |
Why?
|
| Microsomes, Liver | 1 | 2008 | 173 | 0.080 |
Why?
|
| Ketoconazole | 1 | 2008 | 97 | 0.080 |
Why?
|
| Microsomes | 1 | 2008 | 252 | 0.080 |
Why?
|
| Tissue Distribution | 1 | 2012 | 2262 | 0.080 |
Why?
|
| Aged, 80 and over | 6 | 2021 | 58683 | 0.070 |
Why?
|
| Biological Availability | 1 | 2008 | 390 | 0.070 |
Why?
|
| Bile | 1 | 2008 | 297 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 1171 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2012 | 12759 | 0.070 |
Why?
|
| Cell Line, Tumor | 4 | 2024 | 16886 | 0.070 |
Why?
|
| Disease Models, Animal | 4 | 2019 | 18119 | 0.070 |
Why?
|
| Glycoproteins | 1 | 2015 | 2205 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2017 | 3709 | 0.070 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 3858 | 0.070 |
Why?
|
| Reactive Oxygen Species | 3 | 2020 | 2129 | 0.070 |
Why?
|
| Esophageal Neoplasms | 1 | 2017 | 1648 | 0.070 |
Why?
|
| Sesamum | 1 | 2006 | 20 | 0.070 |
Why?
|
| Lung Neoplasms | 2 | 2024 | 13245 | 0.070 |
Why?
|
| Administration, Oral | 2 | 2012 | 3991 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 6493 | 0.070 |
Why?
|
| Hypertension | 3 | 2021 | 8499 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2021 | 5070 | 0.070 |
Why?
|
| Dioxoles | 1 | 2006 | 95 | 0.060 |
Why?
|
| Lignans | 1 | 2006 | 82 | 0.060 |
Why?
|
| Extracellular Matrix | 1 | 2013 | 1723 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 14641 | 0.060 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2010 | 772 | 0.060 |
Why?
|
| Anticoagulants | 1 | 2020 | 4777 | 0.060 |
Why?
|
| Collagen | 1 | 2013 | 2635 | 0.060 |
Why?
|
| Acute Kidney Injury | 1 | 2017 | 1926 | 0.060 |
Why?
|
| Area Under Curve | 1 | 2008 | 1632 | 0.060 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2006 | 361 | 0.060 |
Why?
|
| Trifluridine | 1 | 2024 | 28 | 0.060 |
Why?
|
| Antipsychotic Agents | 1 | 2017 | 3060 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2006 | 703 | 0.050 |
Why?
|
| Head and Neck Neoplasms | 1 | 2017 | 2882 | 0.050 |
Why?
|
| Uracil | 1 | 2024 | 207 | 0.050 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 21017 | 0.050 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2017 | 3217 | 0.050 |
Why?
|
| Vasodilation | 1 | 2006 | 960 | 0.050 |
Why?
|
| Anti-Retroviral Agents | 1 | 2011 | 1780 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2017 | 7980 | 0.050 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2017 | 4023 | 0.050 |
Why?
|
| Base Sequence | 1 | 2012 | 12436 | 0.050 |
Why?
|
| Pandemics | 1 | 2021 | 8611 | 0.050 |
Why?
|
| Ganciclovir | 1 | 2021 | 252 | 0.050 |
Why?
|
| Oligopeptides | 1 | 2006 | 1185 | 0.040 |
Why?
|
| Doxycycline | 1 | 2022 | 341 | 0.040 |
Why?
|
| Dextrans | 1 | 2022 | 573 | 0.040 |
Why?
|
| Metabolic Clearance Rate | 1 | 2020 | 361 | 0.040 |
Why?
|
| Kidney Neoplasms | 1 | 2017 | 4312 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 1 | 2017 | 5349 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 17617 | 0.040 |
Why?
|
| Uterine Artery | 1 | 2019 | 30 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2020 | 378 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 6313 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2006 | 1503 | 0.040 |
Why?
|
| Placenta | 2 | 2019 | 1702 | 0.040 |
Why?
|
| Young Adult | 4 | 2021 | 58808 | 0.040 |
Why?
|
| Blood Circulation | 1 | 2019 | 249 | 0.040 |
Why?
|
| Phenanthrolines | 1 | 2018 | 49 | 0.040 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 418 | 0.040 |
Why?
|
| Polypharmacy | 1 | 2021 | 305 | 0.040 |
Why?
|
| Organic Anion Transport Protein 1 | 1 | 2018 | 6 | 0.040 |
Why?
|
| p-Aminohippuric Acid | 1 | 2018 | 36 | 0.040 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2018 | 217 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2020 | 41256 | 0.040 |
Why?
|
| Probenecid | 1 | 2018 | 73 | 0.040 |
Why?
|
| Cations, Divalent | 1 | 2018 | 168 | 0.040 |
Why?
|
| DNA, Circular | 1 | 2018 | 97 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2024 | 2020 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2020 | 593 | 0.040 |
Why?
|
| Risk Factors | 3 | 2024 | 73809 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 5246 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2017 | 5797 | 0.040 |
Why?
|
| Testosterone | 1 | 2008 | 2471 | 0.040 |
Why?
|
| Cytochromes c | 1 | 2018 | 173 | 0.040 |
Why?
|
| Systole | 1 | 2019 | 936 | 0.040 |
Why?
|
| Ultrasonography, Doppler | 1 | 2019 | 463 | 0.040 |
Why?
|
| Emulsions | 1 | 2017 | 152 | 0.040 |
Why?
|
| Pregnancy | 4 | 2019 | 29742 | 0.040 |
Why?
|
| Superoxides | 1 | 2018 | 386 | 0.040 |
Why?
|
| Estrone | 1 | 2018 | 232 | 0.040 |
Why?
|
| Stereoisomerism | 1 | 2018 | 613 | 0.030 |
Why?
|
| Cytomegalovirus | 1 | 2021 | 755 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 8544 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2024 | 8143 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2017 | 293 | 0.030 |
Why?
|
| Cyclic GMP | 1 | 2017 | 395 | 0.030 |
Why?
|
| Indoles | 1 | 2024 | 1828 | 0.030 |
Why?
|
| Echocardiography, Doppler | 1 | 2019 | 898 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2008 | 4158 | 0.030 |
Why?
|
| Heart Failure | 1 | 2019 | 11593 | 0.030 |
Why?
|
| Natural Language Processing | 1 | 2024 | 1134 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2018 | 23342 | 0.030 |
Why?
|
| Proteinuria | 1 | 2017 | 594 | 0.030 |
Why?
|
| Neoplasms | 2 | 2020 | 22032 | 0.030 |
Why?
|
| HIV-1 | 1 | 2011 | 6850 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2018 | 1866 | 0.030 |
Why?
|
| Emergency Treatment | 1 | 2017 | 496 | 0.030 |
Why?
|
| Mice | 5 | 2019 | 81101 | 0.030 |
Why?
|
| Plasmids | 1 | 2018 | 2275 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2019 | 1136 | 0.030 |
Why?
|
| Prenatal Diagnosis | 1 | 2019 | 1264 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 2018 | 22003 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2024 | 3006 | 0.030 |
Why?
|
| Fetal Development | 1 | 2017 | 766 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 2221 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 4839 | 0.020 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2019 | 1745 | 0.020 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2013 | 266 | 0.020 |
Why?
|
| Disease Management | 1 | 2021 | 2500 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 2019 | 2509 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 6127 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2019 | 14354 | 0.020 |
Why?
|
| Acetylcysteine | 1 | 2010 | 261 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2021 | 3056 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2024 | 8506 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2013 | 1664 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2010 | 481 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2021 | 3261 | 0.020 |
Why?
|
| Rats, Inbred SHR | 1 | 2006 | 186 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2008 | 15637 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 9518 | 0.020 |
Why?
|
| Plant Preparations | 1 | 2006 | 94 | 0.020 |
Why?
|
| HIV Infections | 1 | 2011 | 17275 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2006 | 664 | 0.020 |
Why?
|
| Myocardium | 1 | 2017 | 4690 | 0.010 |
Why?
|
| Age Factors | 1 | 2021 | 18358 | 0.010 |
Why?
|
| Plant Proteins | 1 | 2006 | 369 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2013 | 4087 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2017 | 10416 | 0.010 |
Why?
|
| Hospitalization | 1 | 2021 | 10652 | 0.010 |
Why?
|
| Brain | 2 | 2019 | 26947 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2011 | 4284 | 0.010 |
Why?
|
| Algorithms | 1 | 2019 | 13961 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2006 | 2131 | 0.010 |
Why?
|
| Genotype | 1 | 2011 | 12945 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 13447 | 0.010 |
Why?
|
| Protein Binding | 1 | 2006 | 9311 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 64378 | 0.010 |
Why?
|
Concepts
(280)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(3)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_